Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06541327
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
Sponsor: Ruijin Hospital
View on ClinicalTrials.gov
Summary
This study aims to collect clinical data from adult patients with relapsed or refractory non-Hodgkin's lymphoma (r/r NHL) receiving cellular immunotherapy to establish a large database of cellular immunotherapy for Chinese patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-05-15
Completion Date
2040-12-31
Last Updated
2024-08-19
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
Chimeric Antigen Receptor
CAR-T
Locations (1)
Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China